BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8996893)

  • 1. National considerations in the Nordic countries regarding vaccine licensing.
    Gunnarsson E; Lund A; Høy T; Larsson B; Sihvonen L
    Acta Vet Scand Suppl; 1996; 90():85-7. PubMed ID: 8996893
    [No Abstract]   [Full Text] [Related]  

  • 2. Licensing of veterinary vaccines.
    Fries HH
    Acta Vet Scand Suppl; 1996; 90():83-4. PubMed ID: 8996892
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America.
    Elsken LA; Carr MY; Frana TS; Brake DA; Garland T; Smith K; Foley PL
    Rev Sci Tech; 2007 Aug; 26(2):429-41. PubMed ID: 17892163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Registering, licensing and investigating vaccines in animal disease control (author's transl)].
    Lensing HH; van Leeuwen JM; Oei HL
    Tijdschr Diergeneeskd; 1979 Jun; 104(12):517-20. PubMed ID: 462459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical requirements of veterinary vaccines for registration--FEDESA's point of view.
    Watson J
    Dev Biol Stand; 1992; 79():51-63. PubMed ID: 1286766
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulatory considerations for emergency use of non-USDA licensed vaccines in the United States.
    Hill RE; Foley PL; Carr MY; Elsken LA; Gatewood DM; Ludemann LR; Wilbur LA
    Dev Biol (Basel); 2003; 114():31-52. PubMed ID: 14677675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory considerations for marker vaccines and diagnostic tests in the U.S.
    Foley PL; Hill RE
    Biologicals; 2005 Dec; 33(4):253-6. PubMed ID: 16257538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Veterinary disease legislation can and has to be different].
    Tijdschr Diergeneeskd; 2004 Mar; 129(5):162. PubMed ID: 15032040
    [No Abstract]   [Full Text] [Related]  

  • 10. [Observer in swine husbandry].
    Boissevain I
    Tijdschr Diergeneeskd; 2009 Jan; 134(1):22-3. PubMed ID: 19256217
    [No Abstract]   [Full Text] [Related]  

  • 11. The legal foundation of the production and use of herd-specific vaccines in Europe.
    Attia Y; Schmerold I; Hönel A
    Vaccine; 2013 Aug; 31(36):3651-5. PubMed ID: 23764532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives to the use of animals in R & D and quality control of veterinary vaccines: an industry view.
    Verschueren C; Zänker S
    Dev Biol Stand; 1996; 86():49-51. PubMed ID: 8785991
    [No Abstract]   [Full Text] [Related]  

  • 13. The tradition of animal disease control in the Nordic countries compared to the rest of Europe.
    Pedersen KB
    Acta Vet Scand Suppl; 1996; 90():9-16. PubMed ID: 8996883
    [No Abstract]   [Full Text] [Related]  

  • 14. Veterinary vaccines in an economic and sociopolitical context. The viewpoint of the veterinary pharmaceutical industry.
    Gug M
    Dev Biol Stand; 1992; 79():31-6. PubMed ID: 1286762
    [No Abstract]   [Full Text] [Related]  

  • 15. License requirements and agents licensed.
    Price RJ; Espeseth DA
    J Am Vet Med Assoc; 1972 Feb; 160(4):507-9. PubMed ID: 5063983
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunisation of healthcare workers in the Nordic countries: Variation in recommendations and practices and a lack of assessment.
    Dub T; Søborg B; Andersen PH; Gudnason T; Nøkleby H; Lindstrand A; Carlsson RM; Nohynek H
    Euro Surveill; 2021 Jan; 26(4):. PubMed ID: 33509337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The tobacco problem in the Nordic countries].
    Egsmose T
    Nord Med; 1974 Jun; 89(6):177-84. PubMed ID: 4831783
    [No Abstract]   [Full Text] [Related]  

  • 18. [DNA vaccines for veterinary medicine].
    Gerdts V; Mettenleiter TC
    Dtsch Tierarztl Wochenschr; 2001 Jan; 108(1):3-10. PubMed ID: 11232422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some remarks on the efficacy of vaccines for veterinary use.
    Lensing HH
    Dev Biol Stand; 1992; 79():43-5. PubMed ID: 1286764
    [No Abstract]   [Full Text] [Related]  

  • 20. Standardized incidence rates of total hip replacement for primary hip osteoarthritis in the 5 Nordic countries: similarities and differences.
    Lohmander LS; Engesaeter LB; Herberts P; Ingvarsson T; Lucht U; Puolakka TJ
    Acta Orthop; 2006 Oct; 77(5):733-40. PubMed ID: 17068703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.